Psilocybin and Brain Injury Recovery: Neuroplasticity, Psychedelics & Healing with Dr. Douglas Wingate | E83

Could psilocybin help the brain recover from a concussion or traumatic brain injury (TBI)? Emerging research into psychedelics, neuroplasticity, and psychedelic-assisted therapy is raising fascinating questions about the potential role of psilocybin in brain injury rehabilitation. For people struggling with persistent post-concussion syndrome, brain fog, chronic headaches, cognitive dysfunction, and emotional trauma, could psychedelic-assisted neurorehabilitation offer a new approach to recovery?

In this episode of Life After Impact: The Concussion Recovery Podcast, I'm joined by Dr. Douglas Wingate, a doctor of Chinese medicine, neurological rehabilitation practitioner, author, and licensed psilocybin facilitator. Together, we explore the neuroscience of psilocybin and brain recovery, the differences between microdosing and macrodosing, and how psychedelic experiences may influence neuroplasticity. We also discuss the importance of integrating rehabilitation therapies after a psychedelic experience, the safety considerations involved, and the evolving legal landscape surrounding psychedelic-assisted treatment.

Opening a Window for Neuroplasticity

One of the most fascinating aspects of psychedelic research is the possibility that certain substances may temporarily increase the brain's capacity for change.

For people living with persistent symptoms after a concussion, this raises an intriguing question: What happens when the nervous system becomes stuck in patterns that conventional rehabilitation struggles to change?

Dr. Wingate introduces the concept of a critical window of neuroplasticity and explains why he believes the weeks following a psilocybin experience may be especially important for neurological rehabilitation.

We discuss how therapies such as acupuncture, occupational therapy, speech-language therapy, and other neurorehabilitation approaches might be integrated during this period to reinforce new patterns of neurological function.

Although these mechanisms are being actively investigated, the clinical effectiveness of psilocybin-assisted rehabilitation for traumatic brain injury remains an emerging area of research.

Psilocybin-Assisted Therapy: What Does the Experience Actually Involve?

For someone considering psychedelic-assisted therapy, understanding the process is just as important as understanding the neuroscience.

Dr. Wingate shares his experience as a licensed psilocybin facilitator in Oregon, where he has worked with hundreds of individuals, including people living with persistent neurological symptoms.

We discuss what happens during a facilitated psilocybin session, why preparation and integration are so important, and how emotional experiences may intersect with physical symptoms such as chronic pain, migraines, and brain fog.

We also explore the importance of screening for contraindications, including certain psychiatric conditions and medication interactions, and why psychedelic experiences are not appropriate for everyone.

Microdosing vs. Macrodosing: What's the Difference?

Microdosing psilocybin has received considerable attention for its potential effects on mood, cognition, and mental clarity. But how does taking a subperceptual dose differ from undergoing a full psychedelic experience?

Dr. Wingate explains the differences between microdosing and macrodosing, including their proposed effects on brain network activity, neuroplasticity, and emotional processing.

We also discuss why the scientific evidence for microdosing remains limited, despite growing public interest and reports of individual benefits.

Comparing Psilocybin, Ketamine, MDMA, and Ibogaine

Not all psychedelic or psychedelic-like substances work through the same neurological mechanisms.

In this episode, we explore how psilocybin, ketamine, MDMA, and ibogaine differ in their pharmacology, subjective experiences, potential therapeutic applications, and safety considerations.

Dr. Wingate discusses emerging research involving depression, PTSD, addiction, and neurological rehabilitation, including growing interest in ibogaine for veterans living with traumatic brain injury and psychological trauma.

We also examine why the risks associated with these substances vary considerably, particularly the cardiac safety concerns surrounding ibogaine.

Lion's Mane Mushrooms and Brain Health

Our conversation also takes an interesting detour into lion's mane mushrooms, a medicinal mushroom being studied for its potential effects on nerve growth, neuroinflammation, and cognitive function.

Dr. Wingate shares how he incorporates medicinal mushrooms into his clinical practice and discusses the importance of supplement quality, particularly when choosing mushroom extracts.

The Future of Psychedelic-Assisted Neurorehabilitation

Dr. Wingate is currently writing Opening the Window: Psychedelic-Assisted Neurorehabilitation, a book exploring the neuroscience, clinical considerations, and practical aspects of psychedelic-assisted recovery.

We discuss how access to legal psilocybin services is evolving, what training licensed facilitators undergo, and some of the financial and regulatory barriers that currently limit access.

For anyone interested in psilocybin for concussion recovery, psychedelic-assisted therapy, neuroplasticity, or emerging approaches to traumatic brain injury rehabilitation, this conversation offers a thoughtful introduction to a rapidly developing field.

The potential is intriguing, but important questions remain about safety, effectiveness, patient selection, and long-term outcomes.

Learn More About Dr. Douglas Wingate

Seven Gates Sanctuary: https://sevengatesanctuary.com

Acupuncture, Neuromodulation & Neurorehabilitation: https://acuneuromodulation.com

This episode is educational and does not constitute medical advice or an endorsement of psychedelic use. Psilocybin is not an established or FDA-approved treatment for concussion or traumatic brain injury.